K. Hellmann
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
- Oncology 27
- Cancer Treatment and Pharmacology 16
- Colorectal Cancer Treatments and Studies 8
-
- Lung Cancer Treatments and Mutations 10
- Co-authors
- Rosemary I. Hawkins (6 shared papers)J. S. Weiner (3 shared papers)E.O. Field (3 shared papers)A. J. Salsbury (4 shared papers)A. M. Creighton (1 shared paper)D. F. Tucker (4 shared papers)V J Ferrans (2 shared papers)Brian B. Hasinoff (2 shared papers)
- Journals
- Nature (12 papers)Clinical & Experimental Metastasis (9 papers)The Journal of Physiology (5 papers)The Lancet (5 papers)Cancer (4 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
K. Hellmann
107 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 138
- Oncology 740
- Cardiology and Cardiovascular Medicine 329
- Cancer Research 212
- Toxicology 50
- Hematology 146
Countries citing papers authored by K. Hellmann
This map shows the geographic impact of K. Hellmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Hellmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Hellmann more than expected).
Fields of papers citing papers by K. Hellmann
This network shows the impact of papers produced by K. Hellmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Hellmann. The network helps show where K. Hellmann may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Hellmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1968 | 193 | |
| 2 | 1969 | 148 | |
| 3 | 1998 | 132 | |
| 4 | 1972 | 116 | |
| 5 | 1969 | 89 | |
| 6 | 1970 | 80 | |
| 7 | 1960 | 80 | |
| 8 | 1970 | 77 | |
| 9 | 1965 | 75 | |
| 10 | 1982 | 62 | |
| 11 | Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane. | 1974 | 61 |
| 12 | 1955 | 57 | |
| 13 | 1965 | 57 | |
| 14 | 1953 | 55 | |
| 15 | 1969 | 47 | |
| 16 | 1991 | 47 | |
| 17 | 1964 | 46 | |
| 18 | Fundamentals of cancer chemotherapy | 1987 | 46 |
| 19 | 1966 | 45 | |
| 20 | 1974 | 42 |
About K. Hellmann
K. Hellmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 110 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (16 papers), Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Cancer therapeutics and mechanisms (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Management of metastatic bone disease (5 papers). The work is most often cited by research in Oncology (740 citations), Cardiology and Cardiovascular Medicine (329 citations), Cancer Research (212 citations), Toxicology (50 citations) and Hematology (146 citations). K. Hellmann has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Rosemary I. Hawkins, J. S. Weiner, E.O. Field, A. J. Salsbury, A. M. Creighton, D. F. Tucker, V J Ferrans, Brian B. Hasinoff, Erik Herman and H. Blaschko. Their work appears in journals such as Nature, Clinical & Experimental Metastasis, The Journal of Physiology, The Lancet and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.